miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma

Anna Garbin; Federica Lovisa; Antony B Holmes; Carlotta C Damanti; Ilaria Gallingani; Elisa Carraro; Benedetta Accordi; Giulia Veltri; Marco Pizzi; Emanuele S G d'Amore; Marta Pillon; Alessandra Biffi; Katia Basso; Lara Mussolin

doi:10.3324/haematol.2019.241307

miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma

Haematologica. 2021 Feb 1;106(2):610-613. doi: 10.3324/haematol.2019.241307.

Affiliations

¹ Dept Women's and Children's Health, Clinic of Pediatric Hemato-Oncology, University of Padua, Italy.
² Institute for Cancer Genetics, Columbia University, New York, NY, USA.
³ Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padova, Italy.
⁴ Department of Pathological Anatomy, San Bortolo Hospital, Vicenza, Italy.
⁵ Institute for Cancer Genetics and Dept of Pathology and Cell Biology, Columbia University, New York, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anaplastic Lymphoma Kinase
Cell Line, Tumor
Child
Gene Expression Regulation, Neoplastic
Humans
Lymphoma, Large-Cell, Anaplastic* / genetics
MicroRNAs* / genetics
Receptor Protein-Tyrosine Kinases / genetics
Transcription Factors / genetics

Substances

JunB protein, human
MIRN939 microRNA, human
MicroRNAs
Transcription Factors
Anaplastic Lymphoma Kinase
Receptor Protein-Tyrosine Kinases

Grants and funding

Funding: this work was supported by Fondazione Città della Speranza, Padova, Italy; Fondazione CA.RI.PA.RO, Padova, Italy (grant 17/03 to LM); Camera di Commercio Venezia, Venezia, Italy; Fondazione Roche, Roma, Italy (grant to FL) and Fondazione Umberto Veronesi, Milano, Italy (fellowship to FL); Associazione Italiana contro le Leucemie, sezione provinciale di Treviso (grant to BA).